SEC Filing

SEC Filing Details

Document Details

Form

Filing Date

Jan 11, 2021

Document Date

Jan 11, 2021

Form Description

EFFECT

Filing Group

Other

Company

BioLineRx

Issuer

BioLineRx Ltd.

Filing Formats

View HTML

Press Releases View all

March 22, 2023

BioLineRx Reports 2022 Financial Results and Recent Corporate and Portfolio Updates

March 15, 2023

BioLineRx to Report 2022 Annual Financial Results on March 22, 2023

March 6, 2023

BioLineRx Announces Clinical Trial Collaboration with Washington University School of Medicine to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell Mobilization for Gene Therapies in Sickle Cell Disease

Upcoming Events View all